Aarti Pharma Cash flow Statement
Figures in Rs cr
Consolidated Cash Flow Results
Mar'24
Mar'23
Mar'22
No of Months
12
12
12
Profit Before Tax
300.00
260.00
155.00
Adjustment
94.00
83.00
52.00
Changes In working Capital
-121.00
-31.00
-230.00
Cash Flow after changes in Working Capital
273.00
312.00
-22.00
Cash Flow from Operating Activities
216.00
250.00
-43.00
Cash Flow from Investing Activities
-214.00
-157.00
-138.00
Cash Flow from Financing Activities
9.00
-163.00
260.00
Net Cash Inflow / Outflow
11.00
-71.00
77.00
Opening Cash & Cash Equivalents
12.00
83.00
5.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
Closing Cash & Cash Equivalent
23.00
12.00
83.00
Compare Cash Flow Results of Aarti Pharma
Figures in Rs cr
consolidated Cash Flow Results
Change(INR)
Change(%)
Profit Before Tax
300.49
2399.36
-2,099.00
-87.48%
Adjustment
94.65
212.2
-118.00
-55.40%
Changes In working Capital
-121.85
20.42
-141.00
-696.72%
Cash Flow after changes in Working Capital
273.29
2631.98
-2,358.00
-89.62%
Cash Flow from Operating Activities
216.35
2152.45
-1,936.00
-89.95%
Cash Flow from Investing Activities
-214.56
-2080.52
1,866.00
89.69%
Cash Flow from Financing Activities
9.72
5.27
4.00
84.44%
Net Cash Inflow / Outflow
11.51
77.19
-66.00
-85.09%
Opening Cash & Cash Equivalents
12.12
304.82
-292.00
-96.02%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
23.63
382.01
-359.00
-93.81%
Cash Flow - Snapshot (Consolidated) - Mar'24
YoY Growth in year ended Mar 2024 is -13.50% vs 672.36% in Mar 2023
Mar'24
Mar'23
Change(%)
Cash Flow from Operating Activities
216.35
250.12
-13.50%